Edition:
United Kingdom

Sysmex Corp (6869.T)

6869.T on Tokyo Stock Exchange

8,410JPY
24 Nov 2017
Change (% chg)

¥40 (+0.48%)
Prev Close
¥8,370
Open
¥8,310
Day's High
¥8,440
Day's Low
¥8,290
Volume
238,700
Avg. Vol
539,531
52-wk High
¥8,440
52-wk Low
¥6,010

Latest Key Developments (Source: Significant Developments)

U.S. FDA clears a complete blood cell count test called XW-100 Automated Hematology Analyzer
Monday, 6 Nov 2017 

Nov 6 (Reuters) - U.S. Food and Drug Administration::U.S. Food and Drug Administration says cleared a complete blood cell count test called XW-100 Automated Hematology Analyzer.U.S. FDA says granted premarket clearance and a CLIA waiver for the XW-100 Automated Hematology Analyzer to Sysmex America Inc‍​.U.S. FDA says XW-100 Automated Hematology Analyzer can be run in more health care settings by a wider range of personnel ‍​.  Full Article

R&I affirms Sysmex Corp's rating at "A+" and announces stable outlook -R&I
Monday, 5 Sep 2016 

Sysmex Corp <6869.T> : Rating and Investment Information, Inc. (R&I) affirmed the company's rating at "A+" -R&I .Rating outlook stable -R&I.  Full Article

SYSMEX announces application of International Financial Reporting Standards
Wednesday, 3 Feb 2016 

SYSMEX CORP:To apply International Financial Reporting Standards (IFRS) as the new accounting method, to replace the current Japan-Generally Accepted Accounting Principles.IFRS effective from the Q1 report for fiscal year ending March 2017.  Full Article

EIKEN CHEMICAL enters business alliance with SYSMEX
Friday, 8 Jan 2016 

EIKEN CHEMICAL CO LTD:Enters business alliance with Sysmex Corporation, in the field of urine chemistry testing in overseas markets.  Full Article

BRIEF-U.S. FDA clears a complete blood cell count test called XW-100 Automated Hematology Analyzer

* U.S. Food and Drug Administration says cleared a complete blood cell count test called XW-100 Automated Hematology Analyzer